Megadeals are transforming the EMC sector. Our report provides actionable next steps for positioning your large deal for game-changing M&A success.
In this recorded webcast, we cover approaches to evaluating opportunities during distressed scenarios, developing a plan for change and executing it in order to build value for the future with speed and confidence.
Listen in to hear about common stages of an acquisition and key accounting questions along the way.
US health services deal volume in Q2 2016 increased by approximately 8% from Q1 2016 and 16% on a year-over-year basis. Deal value this quarter increased by nearly 4% compared to Q1 2016, but decreased by 39% when compared to Q2 2015.
Despite a slower start to 2016, we expect CEOs and business leaders will continue to look at M&A and other partnerships as a means to support growth, improve profitability and secure long-term competitiveness. This year’s deals may not be as large or generate the same level of attention as 2014 and 2015, but we expect deals will continue to get done at a reasonable pace.
The US Asset and Wealth Management Deals Insights H1 2016 is now available. This publication includes the deal activity in the asset and wealth management sector such as overall highlights, key announced transactions, and the outlook ahead.
We bring you PwC’s perspective on deal activity in the pharmaceutical and life sciences industry. Each quarterly publication now features two sections that highlight deal activity and insights from a global view.
Our July edition features final Section 108 regulations, temporary and proposed regulations, and private letter rulings
Retail and consumer deal volume continued its positive trajectory, reaching its highest level in the past four quarters.
While deal values remained relative consistent (with the exception of Q3 of 2015), deal volume in the Aerospace & Defense sector declined by 20% (as compared to the previous quarter) to one its lowest levels in recent history.